Research Outcomes and Recommendations for the Assessment of Progression in Cancer Clinical Trials

By Bushnell Will   Stone Andrew  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 949-950

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Type II Error Probability of a Group Sequential Test of Efficacy and Futility, and Considerations for Power and Sample Size

By Dobbins Thomas W.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 378-393

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Placebo Response: Relationship to Outcomes in Trials of Postherpetic Neuralgia

By Irving Gordon  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 739-748

Adis International

Access to resources Recommend Favorite

A Predictive Risk Probability Approach for Microarray Data with Survival as an Endpoint

By Chen Dung-Tsa  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 5, 2008-09 ,pp. : 841-852

Taylor & Francis Ltd

Access to resources Recommend Favorite

On the Lower Predictive Bound Approach for Noninferiority Clinical Trials with Binary Data

By    

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1225-1238

Taylor & Francis Ltd

Access to resources Recommend Favorite